Elevated expression level of 60-kDa subunit of tRNA-guanine transglycosylase in colon cancer

Cancer Letters

Volumn 212, Issue 1, 2004, Pages 113-119

  Ishiwata, Shunji ^a,c   Ozawa, Yasuko ^a   Katayama, Jun ^a   Kaneko, Shuko ^a   Shindo, Hiroki ^a   Tomioka, Yoshihisa ^a   Ishiwata, Toshiyuki ^b   Asano, Goro ^b   Ikegawa, Shigeo ^c   Mizugaki, Michinao ^a,d  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Colon cancer; Differentiation; Expression; Queuosine; tRNA guanine transglycosylase

Indexed keywords

GLYCOSYLTRANSFERASE; TRANSFER RNA;

ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOSOL; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; PENTOSYLTRANSFERASES; TUMOR CELLS, CULTURED;

EID: 3042815958     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.03.009     Document Type: Article

References (30)

1. McCloskey J.A., Crain P.F. The RNA modification database - 1998. Nucleic Acids Res. 26:1998;196-197
2. Rozenski J., Crain P.F., McCloskey J.A. The RNA modification database: 1999 update. Nucleic Acids Res. 27:1999;196-197
3. Yokoyama S., Nishimura S. tRNA-structure, biosynthesis, and function. Soll D., RajBhandy U. Modified Nucleosides and Codon Recognition. 1995;207-223 ASM Press, Washington, DC
4. Masuda M., Nishihira T., Itoh K., Mizugaki M., Ishida N., Mori S. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides. Cancer. 72:1993;3571-3578
5. Itoh K., Konno T., Sasaki T., Ishiwata S., Ishida N., Misugaki M. Relationship of urinary pseudouridine and 1-methyladenosine to activity of leukemia and lymphoma. Clin. Chim. Acta. 206:1992;181-189
6. Itoh K., Mizugaki M., Ishida N. Detection of elevated amounts of urinary pseudouridine in cancer patients by use of a monoclonal antibody. Clin. Chim. Acta. 181:1989;305-315
7. Itoh K., Mizugaki M., Ishida N. Preparation of a monoclonal antibody specific for 1-methyladenosine and its application for the detection of elevated levels of 1-methyladenosine in urines from cancer patients. Jpn. J. Cancer Res. 79:1988;1130-1138
8. Ishiwata S., Itoh K., Yamaguchi T., Ishida N., Mizugaki M. Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA, Tohoku. J. Exp. Med. 176:1995;61-68
9. Kasai H., Ohashi Z., Harada F., Nishimura S., Oppenheimer N., Craine P., et al. Structure of the modified nucleoside Q isolated from Esherichia coli transfer ribonucleic acid, 7-(4, 5-cis-dihydroxy-1-cyclopenten-3-ylaminomethyl)- 7-deazaguanosine. Biochemistry. 14:1975;4198-4208
10. Bjork G. Biosynthesis and function of modified nucleosides. Soll D., RajBhandy U. tRNA-Structure, Biosynthesis, and Function. 1995;165-205 ASM Press, Washington, DC
11. Ito Y., Ito T., Haruna I., Matanabe I. Substituion of guanine for specific base in tRNA by extracts of Ehrlich ascites tumor cells. Nature. 267:1977;467
12. Katze J.R., Farkas W.R. A factor in serum and amniotic fluid is a substrate for the tRNA-modifying enzyme tRNA-guanine transferase. Proc. Natl Acad. Sci. USA. 76:1979;3271-3275
13. Huang B.S., Wu R.T., Chien K.Y. Relationship of the queuine content of transfer ribonucleic acids to histopathological grading and survival in human lung cancer. Cancer Res. 52:1992;4696-4700
14. Aytac U., Gunduz U. Q-modification of tRNAs in human brain tumors. Cancer Biochem. Biophys. 14:1994;93-98
15. Baranowski W., Dirheimer G., Jakowicki J.A., Keith G. Deficiency of queuine, a highly modified purine base, in transfer RNAs from primary and metastatic ovarian malignant tumors in women. Cancer Res. 54:1994;4468-4471
16. Morgan C.J., Merrill F.L., Trewyn R.W. Defective transfer RNA-queuine modification in C3H10T1/2 murine fibroblasts transfected with oncogenic ras. Cancer Res. 56:1996;594-598
17. Deshpande K.L., Seubert P.H., Tillman D.M., Farkas W.R., Katze J.R. Cloning and characterization of cDNA encoding the rabbit tRNA-guanine transglycosylase 60-kilodalton subunit. Arch. Biochem. Biophys. 326:1996;1-7
18. Langgut W., Reisser T. Involvement of protein kinase C in the control of tRNA modification with queuine in HeLa cells. Nucleic Acids Res. 23:1995;2488-2491
19. Morris R.C., Brooks B.J., Eriotou P., Kelly D.F., Sagar S., Hart K.L., et al. Activation of transfer RNA-guanine ribosyltransferase by protein kinase C. Nucleic Acids Res. 23:1995;2492-2498
20. Morris R.C., Galicia M.C., Clase K.L., Elliott M.S. Determination of queuosine modification system deficiencies in cultured human cells. Mol. Genet. Metab. 68:1999;56-67
21. Ishiwata S., Katayama J., Shindo H., Ozawa Y., Itoh K., Mizugaki M. Increased expression of queuosine synthesizing enzyme, tRNA-guanine transglycosylase, and queuosine levels in tRNA of leukemic cells. J. Biochem. (Tokyo). 129:2001;13-17
22. Selden R. Analysis of RNA by Northern hybridization. Ausubel F., Brent R., Kingston R. Current Protocol in Molecular Biology. 1987;4.9 Wiley, New York
23. Dexter D.L., Barbosa J.A., Calabresi P. N, N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res. 39:1979;1020-1025
24. Wilkinson K.D. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes. Fed. Am. Soc. Exp. Biol. J. 11:1997;1245-1256
25. Chung C.H., Baek S.H. Deubiquitinating enzymes: their diversity and emerging roles. Biochem. Biophys. Res. Commun. 266:1999;633-640
26. Spataro V., Norbury C., Harris A.L. The ubiquitin-proteasome pathway in cancer. Br. J. Cancer. 77:1998;448-455
27. Li M., Chen D., Shiloh A., Luo J., Nikolaev A.Y., Qin J., et al. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature. 416:2002;648-653
28. Behrens J. Control of beta-catenin signaling in tumor development. Ann. NY Acad. Sci. 910:2000;21-33. discussions 33-35
29. Taya S., Yamamoto T., Kanai-Azuma M., Wood S.A., Kaibuchi K. The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin. Genes Cells. 4:1999;757-767
30. Yin L., Krantz B., Russell N.S., Deshpande S., Wilkinson K.D. Nonhydrolyzable diubiquitin analogues are inhibitors of ubiquitin conjugation and deconjugation. Biochemistry. 39:2000;10001-10010